Stenocare AS (STENO) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.010x

Based on the latest financial reports, Stenocare AS (STENO) has a cash flow conversion efficiency ratio of 0.010x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr85.84K ≈ $13.43K USD) by net assets (Dkr9.01 Million ≈ $1.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Stenocare AS (STENO) balance sheet quality index to measure how much of total assets are equity-financed.

Stenocare AS - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Stenocare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check STENO operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Stenocare AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stenocare AS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Solis Minerals Ltd V:SLMN	-0.043x
NGS Group AB (publ) ST:NGS	0.030x
GENINCODE PLC LS -01 F:9PL	N/A
tokentus investment AG MU:14D	N/A
Mexican Gold Corp V:MEX	0.953x
Truscreen Group Ltd AU:TRU	-0.502x
James Halstead PLC LSE:JHD	0.106x
Polar Power Inc NASDAQ:POLA	-0.917x

Annual Cash Flow Conversion Efficiency for Stenocare AS (2018–2025)

The table below shows the annual cash flow conversion efficiency of Stenocare AS from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see STENO market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr9.47 Million ≈ $1.48 Million	Dkr-7.21 Million ≈ $-1.13 Million	-0.762x	-137.05%
2024-12-31	Dkr-3.47 Million ≈ $-543.48K	Dkr-7.14 Million ≈ $-1.12 Million	2.056x	+628.68%
2023-12-31	Dkr25.82 Million ≈ $4.04 Million	Dkr-10.04 Million ≈ $-1.57 Million	-0.389x	+37.55%
2022-12-31	Dkr24.14 Million ≈ $3.78 Million	Dkr-15.03 Million ≈ $-2.35 Million	-0.623x	-87.79%
2021-12-31	Dkr40.24 Million ≈ $6.30 Million	Dkr-13.34 Million ≈ $-2.09 Million	-0.332x	-37.22%
2020-12-31	Dkr52.57 Million ≈ $8.23 Million	Dkr-12.70 Million ≈ $-1.99 Million	-0.242x	-27.96%
2019-12-31	Dkr13.47 Million ≈ $2.11 Million	Dkr-2.54 Million ≈ $-398.12K	-0.189x	+30.65%
2018-12-31	Dkr20.47 Million ≈ $3.20 Million	Dkr-5.57 Million ≈ $-872.16K	-0.272x	--

About Stenocare AS

CO:STENO Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$6.35 Million

Dkr40.60 Million DKK

Market Cap Rank

#28096 Global

#131 in Denmark

Share Price

Dkr0.94

Change (1 day)

-3.69%

52-Week Range

Dkr0.68 - Dkr2.72

All Time High

Dkr37.18